Date: | --/--/-- --:--:-- |
Event Id: | E5CZE7S3X |
Action Type: | ACQUISITION |
Action Status: | ANNOUNCED |
Acquirer Symbol: | |
Target Symbol: | NARI |
Updated: | --/--/-- --:--:-- |
Purchase Price Per Share: | 80 |
Price Per Share Currency: | USD |
News References: | https://www.globenewswire.com/news-release/2025/01/06/3004972/0/en/Stryker-announces-definitive-agreement-to-acquire-Inari-Medical-Inc-providing-entry-into-high-growth-peripheral-vascular-segment.html |
Action Notes
Stryker has entered into a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. for $80 per share in cash. Under the terms of the agreement, Stryker will commence a tender offer for all outstanding shares of common stock of Inari for $80 per share in cash. Completion of the tender offer is subject to a minimum tender of at least a majority of then-outstanding Inari common shares, the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act and other customary conditions. Following successful completion of the tender offer, Stryker will acquire all remaining shares not tendered in the offer through a second step merger at the same price as in the tender offer. The transaction is anticipated to close by the end of Q1 2025, subject to customary closing conditions.